contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


neodynamics-to-present-neonaviar-at-the-british-society-of-breast-radiology-meeting-in-belfast-on-5-7-november-2023

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.

NeoDynamics

NeoDynamics will participate in the British Society of Breast Radiology (BSBR) meeting in Belfast on 5-7 November 2023, which is one of the busiest events in the UK breast radiology calendar...

<div class="mfn-preamble"><p><strong>NeoDynamics will participate in the British Society of Breast Radiology (BSBR) meeting in Belfast on 5-7 November 2023, which is one of the busiest events in the UK breast radiology calendar with representation from most major hospitals in the UK.</strong></p></div><div class="mfn-body"><p>NeoDynamics AB (Nasdaq First North Growth Market Stockholm: NEOD. ST), will present the company’s innovative biopsy system, NeoNavia® at the BSBR event where the system will be available for practitioners to try. Initial feedback on the system is very promising with UK radiologists reporting improved control due to the pulse technology. Another reported major benefit is the time saved as it is possible to switch between different needle types within 30 seconds.<br>“It’s great to finally have the complete system with all three needle options available to demonstrate. We have already secured some initial orders and the BSBR provides the platform to start growing the business in 2024” says Ian Galloway, Country Manager, UK &amp; Ireland.</p></div><div class="mfn-footer mfn-contacts mfn-ea9d1b8a5af1"><p><strong class="mfn-heading-1">For further information, please contact:</strong><br>Anna Eriksrud, CEO NeoDynamics AB, phone +46708 444&nbsp;966 or e-mail <a rel="noopener" href="mailto:anna.eriksrud@neodynamics.com">anna.eriksrud@neodynamics.com</a><br>Ian Galloway, Country Manager UK &amp; Ireland, phone +447885 369 062 or e-mail <a rel="noopener" href="mailto:ian.galloway@neodynamics.com">ian.galloway@neodynamics.com</a></p></div><div class="mfn-footer mfn-2d817adef89e"><p><strong class="mfn-heading-1">About NeoNavia</strong><br>NeoNavia is a modern biopsy system with a completely new patented pulse technology intended for ultrasound-guided tissue sampling. Each needle type is driven by the pulse technology providing a more controlled needle insertion and precise placement of the needle in the tumor whilst enabling high-quality tissue samples from both breasts and lymph nodes. The pulse biopsy system NeoNavia is designed to offer clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment.</p></div><div class="mfn-footer mfn-about mfn-67d0674826f8"><p><strong class="mfn-heading-1">About NeoDynamics</strong><br>NeoDynamics AB is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound-guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. NeoNavia is evaluated for breast cancer diagnosis&nbsp;at leading clinics in&nbsp;Europe and launches in USA during 2023. NeoDynamic’s shares are listed on Nasdaq First North Growth Market Stockholm (ticker: NEOD). The company’s Certified Adviser is Redeye AB.</p></div><div class="mfn-footer mfn-53aa4de9759f"><p><strong class="mfn-heading-1">About Karolinska Institute</strong><br>The Karolinska Institute is consistently ranked amongst the world's best medical schools, ranking 6th worldwide for medicine in 2021. The Nobel Assembly at the Karolinska Institute awards the Nobel Prize in Physiology or Medicine.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/7923c2ca-704c-494f-be6f-227ed86f59fd/neodynamics-to-present-neonavia-r-at-the-british-society-of-breast-radiology-meeting-in-belfast-on-5-7-november-2023.pdf" class="mfn-generated mfn-primary">NeoDynamics to present NeoNavia® at the British Society of Breast Radiology meeting in Belfast on 5-7 November 2023</a></p></div>

NeoDynamics to present NeoNavia® at the British Society of Breast Radiology meeting in Belfast on 5-7 November 2023

Talouden myyttejä murtamassa: Saksan teollisuus on menneen talven lumia

Federal Reserven korkopäätös: Riidankylväjät vauhdissa

Taloustieteen myyttejä murtamassa: Datakeskusinvestoinnit johtavat aina vain parempaan tekoälyyn

Nousuviikko takana, USA:n työllisyystaantuma ei edelleenkään luvuissa

USA:n työllisyysluvut: Taapertaen kohti vuoden loppua